CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- 10-Q/A Report 10-Q/A
- SC 13G/A Stake Amended Statement of Ownership
- NT 10-Q Other NT 10-Q
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Restatement · Regulation FD disclosure
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
Page 9 of 69 · 1,379 filings